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Abstract
Mutations in the human gene MCPH1 cause primary microcephaly associated with a unique cellular phenotype with
premature chromosome condensation (PCC) in early G2 phase and delayed decondensation post-mitosis (PCC
syndrome). The gene encodes the BRCT-domain containing protein microcephalin/BRIT1. Apart from its role in the
regulation of chromosome condensation, the protein is involved in the cellular response to DNA damage. We report
here on the first mouse model of impaired Mcph1-function. The model was established based on an embryonic stem
cell line from BayGenomics (RR0608) containing a gene trap in intron 12 of the Mcph1 gene deleting the C-terminal
BRCT-domain of the protein. Although residual wild type allele can be detected by quantitative real-time PCR cell
cultures generated from mouse tissues bearing the homozygous gene trap mutation display the cellular phenotype of
misregulated chromosome condensation that is characteristic for the human disorder, confirming defective Mcph1
function due to the gene trap mutation. While surprisingly the DNA damage response (formation of repair foci,
chromosomal breakage, and G2/M checkpoint function after irradiation) appears to be largely normal in cell cultures
derived from Mcph1
gt/gt mice, the overall survival rates of the Mcph1
gt/gt animals are significantly reduced compared to
wild type and heterozygous mice. However, we could not detect clear signs of premature malignant disease
development due to the perturbed Mcph1 function. Moreover, the animals show no obvious physical phenotype and no
reduced fertility. Body and brain size are within the range of wild type controls. Gene expression on RNA and protein
level did not reveal any specific pattern of differentially regulated genes. To the best of our knowledge this represents
the first mammalian transgenic model displaying a defect in mitotic chromosome condensation and is also the first
mouse model for impaired Mcph1-function.
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Introduction
Mitosis is the fundamental process ensuring the proper
segregation of replicated chromatids to the daughter cells. At the
beginning of mitosis the apparently amorphous interphase
chromatin is organized into individual chromosomes with a pair
of separated sister chromatids. This process is referred to as
chromosome assembly, implying chromosome condensation and
sister chromatid resolution [1,2]. The assembled chromosomes
become attached to the spindle tubules in prometaphase and sister
chromatids are segregated into daughter cells in anaphase. Among
the earliest events in mitosis are the onset of chromosome
condensation and the separation of mature centrosomes. Cell
entry into mitosis is under the control of a tightly regulated
network of protein kinases, cyclins and protein phosphatases [3].
Understanding the structural and molecular basis of mitotic
chromosome condensation and segregation remains a basic
challenge in cell biology.
The first description of a disorder in man affecting chromosome
condensation was reported in 2002 (OMIM 606858) [4]. Cultures
of patients cells display high numbers of prophase-like cells (up to
20%) due to premature chromosome condensation (= PCC
syndrome) in early G2-phase commencing already 1 hour after
completion of S-phase and delayed decondensation post-mitosis.
In 2004, we demonstrated that PCC syndrome and MCPH1
primary microcephaly (OMIM 251200) are allelic disorders, both
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encoding microcephalin/BRIT1 [5,6]. The two conditions share
the common cellular phenotype of misregulated chromosome
condensation. We demonstrated that siRNA-mediated depletion
of MCPH1-mRNA is sufficient to reproduce this phenotype and
that the condensation defect is mediated by condensin II [5,7].
These findings implicated microcephalin/BRIT1 as a novel
regulator of chromosome condensation and linked the apparently
disparate fields of neurogenesis and chromosome biology.
The full length human MCPH1-encoded protein microcepha-
lin/BRIT1 encompasses 835 amino acids and has one N-terminal
and two C-terminal BRCT-domains (BRCT = BRCA1 C-
terminal). The mouse ortholog shares the same domain structure
and encodes a protein of 822 amino acids. The structure is
evolutionary conserved in metazoans. Genes with an equivalent
structure are even found in the two main invertebrate model
organisms, Drosophila melanogaster (GeneID 36372) and Caenorhabditis
elegans (GeneID 173252) [8].
BRCT-domains are found predominantly in proteins involved
in cell cycle checkpoint control and DNA repair [9,10]. Therefore,
it was speculated that microcephalin/BRIT1 might play a role in
DNA damage response and checkpoint control, in addition to its
role in chromosome condensation. Evidence that microcephalin/
BRIT1 might be involved in checkpoint control comes mainly
from experiments using RNA interference. A severe impairment of
the G2/M DNA damage checkpoint in human U2OS cells was
reported after depletion of microcephalin/BRIT1 by RNAi.
Microcephalin/BRIT1-depleted U2OS cells displayed a loss of
G2/M checkpoint control allowing cells to proceed into mitosis
despite exposure to considerable doses of ionizing irradiation (3–
10 Gy) [11,12]. Furthermore, protein levels of the checkpoint
mediator BRCA1 and the checkpoint kinase CHK1 were
decreased following treatment with MCPH1-siRNAs. However,
in patient cells with MCPH1 truncating mutations no downreg-
ulation of BRCA1 and CHK1 was observed [13]. Alderton et al.
found microcephalin/BRIT1 to function downstream of CHK1 in
the ATR-dependent damage response pathway that affects
CDC25A stability and G2/M-checkpoint arrest after replication
fork stalling.
Rai et al. postulated that MCPH1 is a tumor suppressor gene.
Copy number and expression of MCPH1 were reduced in 35 of 87
(40%) advanced epithelial ovarian tumors and in 72% of 54 breast
cancer specimens. MCPH1 expression was inversely correlated
with genomic instability and metastasis. They also detected a
mutation resulting in a premature stop codon in exon 11 and
subsequent deletion of the C-terminal BRCT-domains in one of
ten breast cancer samples. There was loss of heterozygosity in the
other allele of MCPH1 [14]. Furthermore, these authors showed
that microcephalin/BRIT1 co-localizes to DNA damage response
proteins, such as MDC1, 53BP1, NBS1, and phosphorylated
ATM and is required for the activation of these proteins. The
mutated MCPH1-transcript detected in the breast cancer specimen
described above was unable to complement the defective
activation of DNA damage response proteins, in contrast to full
length MCPH1.
Recently, it was reported that the ability of hMCPH1 to localize
to the sites of DNA double-strand breaks depends on its C-
terminal tandem BRCT domains [15] and is mediated by
phosphorylated H2AX–termed cH2AX. These findings correlate
with data obtained by the cloning and expression of chicken Mcph1
[16]. Also very recently it was shown that microcephalin/BRIT1
not only interacts with condensin II in the regulation of
chromosome condensation but also in the homologous repair of
DNA damage [17].
In addition, microcephalin/BRIT1 appears to have also
centrosomal functions. Prolonged treatment of MCPH1 patient
lymphoblastoid cell lines with nocodazole results in supernu-
merary centrosomes, a feature also observed in Seckel
syndrome [13]. It was demonstrated in model organisms that
isoforms of microcephalin/BRIT1 localize to the centrosome
[16,18]. In Drosophila it appears to be essential for the
coordination of mitosis in the syncytical embryo as in mcph1
mutant flies mitotic entry is slowed with prolonged prophase
and metaphase stages, while centrosomes are frequently
detached and prematurely separated. As a consequence
centrosome and nuclear cycles become uncoordinated, resulting
in arrested embryonic development [18,19]. Microcephaly
occurring in MCPH1 primary microcephaly may be due to a
defective centrosomal function of microcephalin/BRIT1 influ-
encing the number of proliferative, symmetric cell divisions of
neuronal stem cells during neurogenesis.
Many of the accumulating data reported for microcephalin are
based on RNAi-experiments. It will be relevant to back up this
information by data provided from model organisms. A model
system with misregulated chromosome condensation will also be
useful to obtain further insights into the molecular mechanisms
shaping the mitotic chromosomes.
We present here the first mouse model with defective Mcph1-
function. The model was generated using a mouse embryonic stem
cell line containing a gene trap in intron 12 of the Mcph1 gene
(GeneID 244329) deleting the C-terminal BRCT-domain of the
protein. In our study we show that the gene trap mutation impairs
the function of the protein resulting in misregulated chromosome
condensation in proliferating cells of animals homozygous for the
trapped allele.
Materials and Methods
Identification of the Gene Trap Insertion Site
Long range PCR kit (Roche) was applied for candidate forward
primers designed for 5 Kb intervals of intron 12 of the Mcph1-
gene. One common reverse primer specific to the vector sequence
was applied in all reactions (59- CTTCCTGTAGCCAGCTTT-
CATCAACATT-39). Amplification with forward primers P18 (59-
GAGGAAAAATCTCTCACATCTCCACACG-39) and P19 (59-
TCAAGTTCACCTCCAACTAAAGGGAAGG–39) resulted in
the amplification of distinct PCR-products of approximately
6.5 kb and 1.5 kb, respectively. PCR conditions were used as
follows: 92uC for 10 sec for the first 10 cycles then 15 sec in the
next 25 cycles, extension at 68uC for 4 min in the first 10 cycles
adding 20 sec per cycle for the next 25 cycles. Final extension was
at 68uC for 7 min. Subsequently, the PCR products were analyzed
by sequence analysis on a 3730 DNA Analyzer (Applied
Biosystems) applying standard procedures.
Quantitative Real-Time PCR
For relative quantification total RNA was isolated from brain,
liver and spleen of 3 Mcph1
gt/gt and 3 wild type mice (of same
age and generation) using TRIzol (Invitrogen), in accordance
with the manufacturer’s instructions. First strand synthesis was
performed with 2 mg of total RNA using SuperScript III First-
Strand Kit (Invitrogen). First strand samples from 50 ng RNA
were used for real-time PCRs. qPCRs were carried out using
POWER SYBRH GREEN PCR Master Mix (Applied Biosys-
tems) and Applied Biosystems 7500 Real-Time PCR System
according to the manufacturer’s recommendations. Forty five
two-step cycles were performed (15 s at 95uC and 60 s at 60uC).
Relative quantification was achieved by the DDCt-method using
Mcph1 Mouse Model
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TGCAG-39 and R1: 59-GGCGCTATGAACATCTTCGG- 39,
F2: 59-ACTCTCTGAAACCTTCCCTGCAG-39 and R2: 59-
GGCGCTATGAACATCTTCGG-39, and Hprt-specific primers
F: 59-TGCTCGAGATGTCATGAAGG-39 and R: 59-AATC-
CAGCAGGTCAGCAAAG-39.
For absolute quantification the PCR products of Hprt and the
wild type and trap alleles of Mcph1 were cloned using the Topo
2.1 Cloning Kit (Invitrogen). The Mcph1-specific primers
described above and a primer pair amplifying the Mcph1-trap
fusion (F: 59-TAGAGTTGGGCCACTGGATTTCT-39 and R:
59-CTGCGTTCTTCTTCTTTGGTTTTC-39) were used for
PCR cloning. The plasmid concentrations were determined by
UV photometry. The plasmids were diluted to generate standard
curves from 10
9 copies/mlt o1 0
0 copies/ml. First strand synthesis
was performed as described above. First strand samples from
50 ng RNA were used for real-time PCRs. Homogeneous loading
was controlled by comparing the Ct-values of b-actin primers F:
59-CGTGAAAAGATGACCCAGATCA-39,R :5 9-GGGACAG-
CACAGCCTGGAt-39. The respective Ct-values of the Hprt, and
Mcph1 wild type and trap alleles were related to the standard
curves. The absolute number of target copies per microgram total
RNA was calculated and compared in brain, liver, spleen, and
fibroblasts between wild type and Mcph1
gt/gt mice.
Generation of the Mcph1 Deficient Mice
The RR0608 ES cells (129/OLA) were microinjected into
blastocysts from C57BL/6 mice. Chimeras were identified by coat
color and crossed with wild type C57BL/6. Germline transmission
resulted in two heterozygote animal, a male and a female, which
were crossed inter se. Pairing of heterozygous animals resulted in
viable homozygous offspring. All animal experiments were
performed according to institutional guidelines. Mice were
genotyped by PCR with primers flanking the integration site for
the wild type allele (wt-F 59-AGCCCAGAGCCTAGAGAGGA-
39, wt-R 59-ATCTGTGCATAGGAGACAACACTGATAG-39)
and a forward primer flanking the 59-integration site and a reverse
primer specific for the trap vector identifying the trapped allele (gt-
F5 9-TGCCTATGTGCAATGTTTCAA-39, gt-R 59-TGACCT-
TGGGCAAGAACATA-39) resulting in PCR products of 989 bp
and 181 bp, respectively. PCR conditions for the wild type allele
were 96uC for 10 s, 56.5uC for 45 s, 70uC for 1 min 15 s for a
total of 35 cycles. The trap allele was amplified by 35 cycles of
96uC for 10 s, 52uC for 45 s, 72uC for 45 s.
Establishment of Fibroblast Cultures
Mouse tail tips or peritoneum pieces were washed in Earle’s
Medium containing antibiotics, cut into small pieces and
transferred to falcon tubes for trypsin-collagenase treatment. Tail
tips were trypsinized for 1 h at 37uC with 0.5% trypsin-EDTA.
Subsequently, the supernatant was removed and replaced by 10%
collagenase/DMEM for 1 h at 37uC. The resulting cell suspension
was washed and transferred to culture flasks. The cells were grown
in DMEM supplemented with 15% fetal calf serum and
antibiotics.
Chromosome Preparation and PLC-Assay
Cytogenetic preparations were performed on fibroblasts using
standard diagnostic laboratory procedures to prepare metaphase
spreads. Slides were stained by immersion in fresh 10% Giemsa
stain for 10 min. 2,000 nuclei were counted and percentage of
prophase/prophase-like and metaphase nuclei was determined
among total nuclei.
Analysis of Cell Cycle Progression by
3[H]-Thymidine
Autoradiography
Logarithmically growing mouse fibroblast cell lines were
exposed for 10 min to 1 mCi/ml
3[H]-thymidine, washed twice
with 37uC pre-warmed filtered sterile PBS, and harvested at one-
hour intervals (1–4 hours after labeling). The slides were coated
with nuclear track emulsion (Ilford) and exposed for one week.
Autoradiograms were developed and stained with Giemsa. The
labeling patterns of 100 prophases were scored for each time.
Decondensation Assay
Cytokinesis of primary mouse fibroblasts was blocked with
6 mg/ml of Cytochalasin B for 2 hs before harvesting. Cells were
subjected to hypotonic treatment with 0.075 M of KCl for
2 min and were fixed two times with a 3:1 mix of methanol and
acetic acid, and the last fixation was in a 7:1 mix of methanol
and acetic acid. Nuclei were stained with Giemsa. Postmitotic
cells were distinguished by their binucleate appearance. Slides
were coded and n$100 binucleated cells were counted from
each sample.
Chromosomal Breakage Analysis
Logarithmically proliferating diploid fibroblast cultures were
irradiated using an X-ray source (Muller MG 150, Ua =100 kV,
I=10 mA, filter 0.3 mm Ni, dosis rate: 2.1 Gy/min). Chromo-
somes were prepared at 3 hs and 6 hs after the time of irradiation
as described above. Slides were coded and 25 metaphases were
scored for each sample at each time point.
Flow Cytometry
Primary fibroblasts from three Mcph1
gt/gt and three wildtype
mice were seeded (4.000 cells/cm
2) in duplicate flasks. The cells
were allowed to attach overnight. One culture of each strain was
exposed to high-energy X-ray photons provided by a linear
accelerator with dosimetry. The dosage level equaled 4 Gy.
After another 2 h of incubation, matched irradiated and
unirradiated cultures were harvested. The cells were washed
in PBS and fixed in 2% para-formaldehyde. Permeabilization
was by 90% methanol for 30 min on ice. Phospho-Histone H3
was detected by mouse monoclonal anti p-H3 primary antibody
(Cell Signaling Technology, #9706) at a dilution of 1:25 and
goat anti-mouse IgG (H+L) Alexa Fluor 647-conjugated
secondary antibody (Molecular Probes, A21237). DAPI was
used as counterstain for DNA content and cell cycle distribu-
tion. HeCd and Ar laser excitation and fluorescence detection
was performed on an analytical flow cytometer (Becton
Dickinson, LSRII). p-H3-positive signals were expressed relative
to all recorded events.
Preparation of Meiotic Chromosomes
Meiotic chromosomes were prepared from the testes of adult
male mice by conventional chromosome preparation [20]. Briefly,
the testes were cut into small pieces. After hypotonic treatment for
15 min at room temperature, the cells were fixed with acetic
acid:methanol (1:3). The cell suspension was dropped onto slides
and stained with Giemsa.
Preparation of Testes Sections
Testes were fixed with Methacarn (60% methanol, 30%
chloroform, 10% acetic acid), dehydrated in ethanol, substituted
with xylene, and embedded in paraffin. Paraffin sections (5 mm
thick) were stained with HE.
Mcph1 Mouse Model
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Cells were grown on cover slips to approximately 70%
confluency. Cells were fixed with 2% paraformaldehyde in PBS
for 30 min. Permeabilization was performed on ice with 0.5%
triton X-100/PBS for 5 min. Cover slips were blocked for 1 h in
3% BSA/PBS. Anti- p-H3-S10 (abcam), anti-Aurora B (abcam),
anti-53BP1 (Novus), and anti-H2AX-Ser139 (Upstate) were used
for immunodetection. Fluorescence staining was performed with
secondary antibodies anti-mouse-TRITC (Sigma) and anti-rabbit
(SantaCruz). Nuclei were counterstained with DAPI. For the
analyses of the formation of DNA repair foci, cell cultures were
treated for two hours before fixation with 0.5 mg/ml of the
radiomimetic agent adriamycin or 10 mg/ml of the radiomimetic
agent bleomycin to induce DNA double strand breaks.
Magnetic Resonance Imaging
To assess cerebral volume in vivo, wild-type (n=5), and
homozygous Mcph1
gt/gt (n=11) were anaesthetized with 3%
isoflurane (Forene, Abbot, Wiesbaden, Germany) mixed with O2
using a Vapor 2000 Vaporizer (Dra ¨ger Medical, Lu ¨beck,
Germany) and a flowmeter for O2/N2O. During the remainder
of the imaging session anaesthesia was maintained with 1.5–2.0%
isofluran. To ensure constant body temperature of 37uC mice
were placed on a heated circulating water blanket. Respiration was
monitored using Small Animal Monitoring & Gating System (SA
Instruments, Stony Brook, New York, USA).
Brain images were acquired using a 7 Tesla Bruker rodent
scanner (Pharmascan 70/16AS, Bruker BioSpin, Ettlingen,
Germany) and a 20 mm Quadrature-Volume-Resonator.
High-resolution T2-weighted images of the whole brain
including olfactory bulb and cerebellum were acquired with a
2D turbo spin-echo sequence (TR/TE =4059/36 ms, RARE
factor 8.4 averages). 35 axial slices with a slice thickness of
0.5 mm, a field of view of 2.8562.85 cm and a matrix of 2566256
were positioned over the whole brain resulting in an in plane
resolution of 111 mm.
Calculation of Brain Volume
Calculation of brain volume was carried out using Analyze 5.0
software (AnalyzeDirect, Inc.; Lenexa USA). Brains were assigned
with a Region of Interest Tool resulting in 3D object maps for
each single mouse brain. The volumes of 3D maps were then
automatically calculated.
Brain Proteome Analysis
Control and Mcph1
gt/gt mice at 15 weeks of age (n=4) were
sacrificed by cervical dislocation. All brains were immediately
removed, weighted, the cortex removed, snap-frozen in liquid
nitrogen and stored at 280uC for protein extraction. Total protein
extracts were prepared from brain tissue. Frozen tissue, 1.6 parts
v/w of buffer P (50 mM TRIZMA Base (Sigma-Aldrich,
Steinheim, Germany), 50 mM KCl and 20% w/v glycerol at
pH 7.5), supplemented with a final CHAPS concentration of 4%
w/v in the sample, 0.08 parts of protease inhibitor solution I (1
Complete tablet (Roche Applied Science, Mannheim, Germany)
dissolved in 2 mL of buffer 1) and 0.02 parts of protease inhibitor
solution II (1.4 M pepstatin A and 1 mM phenylmethylsulfonyl
fluoride in ethanol) were ground to fine powder in a mortar pre-
cooled in liquid nitrogen. The tissue powder was transferred into a
2 mL tube (Eppendorf, Hamburg, Germany), quickly thawed and
supplied with glass beads (0.034 units of glass beads per combined
weight of tissue, buffers and inhibitors in mg; glass beads,
2.5 mm60.05 mm diameter, Worf Glaskugeln GmbH, Mainz,
Germany). Each sample was sonicated 6 times in an ice-cold water
bath for 10 s each, with cooling intervals of 1 min 50 s in between.
The homogenate was stirred for 30 min in buffer P without
CHAPS at 4uC in the presence of 0.025 parts v/w of benzonase
(Merck, Darmstadt, Germany) and a final concentration of 5 mM
magnesium chloride in the sample. Subsequently, 6.5 M urea and
2 M thiourea were added, and stirring was continued for 30 min
at room temperature until urea and thiourea were completely
dissolved. The protein extract was supplied with 70 mM
dithiothreitol (Biorad, Munich, Germany), 2% v/w of ampholyte
mixture Servalyte pH 2–4 (Serva, Heidelberg, Germany), correct-
ed by the amount of urea added (correction factor = sample
weight prior to addition of urea/sample weight after addition of
urea), and stored at 280uC. Protein concentrations were
determined in sample aliquots without urea using Biorad DC
Protein Assay according to the protocol supplied by the
manufacturer.
Two-Dimensional Gel Electrophoresis
Protein samples were separated by the large-gel 2-DE technique
developed in our laboratory as described previously [21]. The gel
format was 40 cm (isoelectric focusing)630 cm (SDS-PA-
GE)60.75 mm (gel width). For isoelectric focusing (IEF) using
the carrier ampholyte technique, we applied 6 L (,20 g/L)
protein extract of each sample to the anodic end of an IEF-gel and
used a carrier ampholyte mixture to establish a pH-gradient from
3 to 10. Proteins were visualized in SDS-PAGE polyacrylamide
gels by high sensitivity silver staining. 2-D gels were dried as
described [21] and scanned at 300 dpi and 16 bits gray scale using
a scanner (Microtek Scan Maker 9800XL, Evestar GmbH,
Willich, Germany). The 2-D gel images were subsequently saved
in Tiff format to avoid loss of quality due to compression.
After up-loading the 2-D gel images, protein spot patterns were
evaluated by Delta2D imaging software version 3.6 (DECODON,
Greifswald, Germany) as was already described recently in detail
elsewhere [22]. Delta2D is our standard 2-D gel evaluation
software and was validated already in many of our studies
[23,24,25,26,27,28]. Briefly, 2-D spot patterns of Mcph1
gt/gt and
control mouse brains were matched using the Delta2D ‘‘exact’’
mode matching protocol. First sample pairs (Mcph1
gt/gt and
control) were matched individually. Subsequently, all Mcph1
gt/gt
gels were matched to create a ‘‘match link’’ between all 2-D spot
patterns using match vectors [22]. Using ‘‘union’’ mode a fusion
image was generated, including the visible spots for each 2-D gel.
Only the fusion image was used for spot detection employing the
following settings for Delta2D: local background region: 100,
average spot size: 1, sensitivity: 100%. Spots were not edited
manually after spot detection. About 2,000 spots on the fusion
image were transferred to all other 2-D gel images for each time
point. This ensures that for each stage investigated the ID for each
spot on a gel is identical. Relative spot volume intensities (fractions
of 100%) were used for quantitative protein expression analysis.
After background subtraction, normalized spot intensity values
were copied into Excel spreadsheets for statistical analysis. Data
sets were analyzed applying a paired Student’s t-Test.
Expression Profiling
Total RNA was isolated from brain, liver and spleen of 3
MCPH1
gt/gt and 3 wild type mice (of same age and generation)
using TRIzol (Invitrogen), in accordance with the manufac-
turer’s instructions. Aliquots of RNA samples (500 ng) were
amplified according to the specifications of the Illumina Total
Prep RNA Amplification Kit (Ambion, Austin, TX, USA). The
cRNA samples were applied to the arrays of Sentrix
H Mouse-6
Mcph1 Mouse Model
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was developed with streptavidin-Cy3, and the Sentrix Bead-
Chip was scanned with the Illumina BeadArray Reader. The
DiffScore parameters were used to determine gene expression
in the Illumina BeadStudio software program (v3.1.3.0). We
utilized the rank-invariant method algorithm provided by
BeadStudio Gene Expression Module for normalization of
sample signals.
Results
Characterization of the Gene Trap in the ES Cell Line
RR0608
The gene trap vector used by BayGenomics contains a splice-
acceptor sequence upstream of a reporter gene (b–geo, a fusion of
b–galactosidase and neomycin phosphotransferase). The insertion
of the vector into an intron of a gene results in a fusion transcript
that joins the sequence of the exon lying 59- to the insertion site
and the b-geo reporter resulting in a truncated traceable fusion
protein [29]. In the ES cell line RR0608 the gene trap vector
inserted between exons 12 and 13 of the Mcph1 gene as identified
by 59RACE (BayGenomics database, http://baygenomics.ucsf.
edu, now moved to http://www.genetrap.org/) resulting in a
truncated protein lacking 97 amino acids in the most C-terminal
BRCT-domain. The mutant allele will be referred to as Mcph1
gt.
The truncated transcript was characterized by RT-PCR using
gene and trap-specific primers and subsequent sequencing.
Sequencing of the PCR product confirmed the fusion of Mcph1
exon 12 and the reporter.
It was crucial to identify the genomic insertion site, as the gene
Angpt2 resides in intron 12 of the Mcph1 gene (Figure 1). Thus, the
insertion of the gene trap may have disrupted Angpt2 which is a
lethal condition in mouse [30]. For this purpose we subdivided the
intron (intron size is 99,179 bp) into sections of approximately
5,000 bp by designing sequence specific forward primers. We then
tried to achieve PCR amplification by long range PCR using a
trap specific reverse primer. PCR using primer P19 (59-
TCAAGTTCACCTCCAACTAAAGGGAAGG-39) resulted in
the amplification of a 1,500 bp product. Subsequent sequencing
of the PCR product determined the insertion site of the trap at the
position 18,778,752 of the genomic sequence (USCS; version July
2007) c.2,176-9,486pGT2lxf, therefore, in a distance of approx-
imately 37,200 bp of exon 1 of the Angpt2 gene (Figure 1A).
Quantitative real time PCR confirmed that the expression of the
Mcph1 wild type transcript is markedly reduced in different tissues
of Mcph1
gt/gt mice. Primer pairs spanning introns 12 or 13 were
used for the amplification of the Mcph1 wild type transcript. The
relative quantification was achieved applying the DDCT method.
Normalization was reached using Hprt as endogenous reference
gene, and RNA from wild type animals was used for standard-
ization. We compared the expression in liver, brain, and spleen of
three Mcph1
gt/gt animals to three controls by relative quantifica-
tion. In Mcph1
gt/gt the mRNA level of wt Mcph1 was reduced to
approximately 9%62.5 in spleen, 19%63.2 in liver, and
Figure 1. Characterization of the gene trap allele. (A) The vector was inserted into intron 12 of the Mcph1 gene. The gene Anpt2 is localized on
the opposite strand within this intron. Flanking Mcph1 exons are displayed in black, Angpt2 exons are displayed in white and the vector is displayed
as grey box. The vector inserted 37.2 kb upstream of exon 1 of Anpt2 and 9.49 kb upstream of exon 13 of Mcph1. (B) Relative quantification of
residual wild type Mcph1-mRNA in tissues of Mcph1
gt/gt animals by real-time PCR. The expression of wild type Mcph1-mRNA is significantly reduced
in all analyzed tissues, although a considerable residual amount of wild type Mcph1-mRNA is detected. (C) The expression levels of the b-geo-fusion-
mRNA compared to residual wild type Mcph1-mRNA in different tissues of Mcph1
gt/gt animals expressed as the ratio of b-geo-fusion-mRNA to wild
type Mcph1-mRNA. Wild type and b-geo-fusion-mRNA are expressed at roughly the same low levels. The absolute numbers of mRNA copies per
microgram RNA were determined by quantitative PCR.
doi:10.1371/journal.pone.0009242.g001
Mcph1 Mouse Model
PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e924228%64.3 in brain, indicating that the Mcph1 genetrap mutation
results - as expected - in a preferential splicing of exon 11 of the
Mcph1-gene to the gene trap vector. Obviously, however,
alternative splicing allows a strongly reduced but still detectable
expression of the wild type allele and this expression varies
between different tissues (Figure 1B).
Residual wild type protein might be able to exert some function,
however with significantly diminished activity due to its reduced
abundance. In addition, even the trap-allele may adopt some
Mcph1-functions because the genetrap truncates only the C-
terminus of the protein. Therefore, we intended to further
characterize the expression from both the wild type- and trap-
allele. Unfortunately, we were not able to detect the wild type
Mcph1 protein by western blotting neither in protein samples from
wild type nor Mcph1
gt/gt animals. Also the b–geo reporter was not
traceable in Mcph1
gt/gt neither by X-gal staining nor by anti-b–
galactosidase antibodies. This may be explained by low expression
rates of Mcph1. Therefore, we decided to perform an absolute
quantification of the mRNAs of both alleles and an endogenous
control gene (Hprt) in the different tissues by real time PCR. The
results revealed that in comparison to the low-abundant
endogenous control gene Hprt, Mcph1 is expressed at very low
levels in all analyzed tissues. In wild type tissues the copy numbers
of Mcph1 per microgram RNA compared to Hprt were 3.761.6
times less in spleen, 10.761.2 times less in liver, and 21.663.7
times lower in brain and accordingly even lower in the tissues of
the Mcph1
gt/gt animals (76.9621.1 times, 45.1612.1 times,
46.363.6, respectively). Thus, our problems detecting the Mcph1
protein can be explained by these very low expression levels.
Surprisingly, the analyses also revealed that the gene trap allele is
expressed at approximately the same low level as the remaining
wild type allele in the tissues of the Mcph1
gt/gt animals (the ratios
of expressed gene trap to wild type allele were 0,85 in brain, 1,07
liver, and 0,68 in spleen, Figure 1c). Therefore, the addition of the
b-geo cassette may either interfere with the regulation of gene
expression or destabilize the mRNA expressed by the trap-allele.
Thus, the low expression level not only may explain our problems
detecting the reporter protein but also infers that it may not be
possible for the fusion protein to substantially adopt Mcph1-
functions.
Phenotypic Description of the Mice
Mcph1
gt/gt animals did not differ significantly in body weight
compared to wild type animals (mean 32.3 g61.8, n=14 vs.
33.5 g62.6, n=12, respectively, unpaired t-testing results in a
two-tailed P-value P=0.193) (Figure 2A). By conventional criteria
this difference is not considered to be statistically significant.
Equally, the proportionate weight of the brains of Mcph1
gt/gt
Figure 2. Evaluation of the physical phenotype of Mcph1
gt/gt mice. Boxplots showing that Mcph1
gt/gt mice do not differ significantly from
wild type animals concerning body weight (P=0.193) (A) and the proportionate weight of their brains (% brain of body weight, P=0.275) (B).
Mcph1
gt/gt mice do not show a reduction in fertility (P=0.441) (C). Kaplan-Meier survival curves of Mcph1
gt/gt compared to wild type mice show
significantly reduced survival rates of Mcph1
gt/gt compared to wild type and heterozygote animals (D).
doi:10.1371/journal.pone.0009242.g002
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0.21, n=14 vs. 1.3260.16, n=12, respectively, P=0.275), (Figure
2B). Measurement of brain volumes by MRI supported these
findings. The average volume of Mcph1
gt/gt brains (n=11) was
522.5 mm
3622.8 compared to 514.4 mm
3610.4 in wild type
animals (n=4). Moreover MRI analyses did not reveal any
obvious malformations of the brain (Figure 3). However, in one of
the 11 Mcph1
gt/gt animals aplasia of the corpus callosum and
atrophy of the 3
rd ventricle was found. Ventricular malformation
indicates a midline defect caused by a developmental disorder of
the forebrain (Figure 3A). This is rarely observed in mice, but as it
represents a single event, it must be rated anecdotal, as long as no
further incidences are found.
Most importantly however, the overall survival is reduced
compared to wild type and heterozygous animals. 21 Mcph1
gt/gt,
17 heterozygous and 15 wt animals were maintained under
standard conditions to examine survival. The difference in survival
develops after animals have reached an age of .65 weeks and is
statistically significant for the comparison of Mcph1
gt/gt and wt
animals (log rank test x
2=4.1818, P=0.0409) as well as the
comparison of Mcph1
gt/gt and heterozygous animals (log rank test
x
2=10.1002, P=0.0015, Figure 2D). Unfortunately, we could so
far not determine the precise causes of deaths for the Mcph1
gt/gt
animals.
Analyses of Chromosome Condensation
Primary fibroblast cultures from 11 Mcph1
gt/gt mice and 12
wild type animals were established from mouse tails and
propagated under standard conditions. Cytological preparations
were made in parallel from those 11 Mcph1
gt/gt and 12 Mcph1
wt
cultures to analyse chromosome morphology. The slides were
coded and the fraction of prophase-like cells (PLCs) was
determined by visual cell counts. 2,000 nuclei were counted from
each sample and the proportion of nuclei with prophase-like
morphology and the metaphase indices were determined.
Mcph1
gt/gt cell lines showed a dramatic increase of nuclei
displaying condensed prophase-like chromatin (7.7%60.8) com-
pared to wild type cell lines (1.0%60.5, x
2=1306.49, p,0.001)
(Figure 4A). In contrast, the metaphase indices were at the same
level: 0.6%60.3 and 0.7%60.2 for gt/gt and wt cell lines,
respectively. The similar metaphase indices confirm similar
proliferative activities in gt/gt and wt/wt cell cultures. Quantita-
tive analyses in 5 heterozygous cell lines revealed no increase in the
proportion of prophase-like cells (1.22%60.5), an observation
arguing against a potential dominant-negative effect of the gene
trap allele.
We determined the timing of chromosome condensation
following S phase by
3[H]-thymidine pulse labeling. For this
purpose, we compared one logarithmically growing diploid
fibroblast cell line and one transformed cell line from Mcph1
gt/gt
mice to wild type cell lines in 1 h intervals (1 h–4 h) by
autoradiography after pulse-labeling with
3[H]-thymidine for
10 min. N$100 prophases or prophase-like cells were scored per
time point and per cell line and the proportion of labeled cells was
determined. We observed a significant difference between the gt/
gt and wt cell lines in the proportion of prophase/prophase-like
cells that were labeled within this period. Already 1 h after the
pulse, 12% of the prophase-like cells of the diploid gt/gt mouse but
none of the prophase cells in the control showed 3H-thymidine
labeling. After 2 h, 42% of PLCs in the diploid Mcph1
gt/gt cells
and 12% of the prophases in wt cells were labeled (see Figure 4B).
Similar results were obtained for the transformed cell lines. 1 h
after the pulse 35% of PLCs were labeled in the Mcph1
gt/gt cell
line compared to only 12% in the wild type (Figure S1).
Consequently, chromosome condensation in the Mcph1
gt/gt cells
starts in the early G2 phase of the cell cycle as soon as 1 h after the
end of the S-phase or even earlier. Thus, the observed premature
chromosome condensation phenotype described in the cells of
human patients with MCPH1-deficiency is also found in mouse
cells homozygous for the trap-allele.
To investigate the chromosome decondensation behavior of the
Mcph1
gt/gt cell lines in the early G1 phase of the cell cycle we
treated three logarithmically growing Mcph1
gt/gt fibroblast cell
lines and three wild type fibroblast cell lines with the inhibitor of
cytokinesis Cytochalasin B. Treatment with Cytochalasin B results
in binucleated cells. Cytological preparations were performed
following 2 hs of Cytochalasin treatment. Consequently, all
binucleated cells must have exited mitosis within these two hours
and, therefore, be in early G1 phase. 19.8% (6 2.7) of binucleated
Mcph1
gt/gt cells displayed condensed chromatin, while only 2.8%
(6 1.2) of wild type binucleated cells showed signs of chromatin
condensation, (x
2=84.32, p,0.001) (Figure 4C). Thus, there is a
delayed decondensation in Mcph1
gt/gt cells.
These data were supported by immunofluorescence analyses. In
normal prophases phosphorylation of histone H3 at serine 10 (p-
H3) usually has spread to the chromosome arms while human
MCPH1 cells show prophase like cells in the G2 phase of the cell
cycle without full phospho-histone H3 labeling (Alderton et al,
2006). Similarly, we observed high numbers of equivalent cells in
Mcph1
gt/gt fibroblast cultures. Figure 4D shows a cell displaying
clearly condensed chromatin with only centromeric p-H3-labeling.
These cells are accordingly in G2 and show prophase-like
condensation but are different from normal prophases on a
molecular level, because in normal prophases histone H3-
phosphorylation has spread out over the whole chromosome arms
(see Figure S2 for an exemplary normal prophase cell). Pairs of
Figure 3. T2-weighted MR images of Mcph1
gt/gt mouse brains.
(A) Different brain sections of the single Mcph1
gt/gt mouse presenting
with hypoplasia of the corpus callosum (dark line, CC) and ventricular
(light structures, V) malformation. (B) The brains of the majority of
Mcph1
gt/gt mice showed normal forebrain anatomy and did not differ
from those of WT animals. (C) Wild type mouse with normal forebrain
anatomy.
doi:10.1371/journal.pone.0009242.g003
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between daughter cells. Following midbody staining with antibod-
ies against Aurora B kinase, we observed a high proportion of post-
mitotic cells with clearly condensed chromatin (Figure 4D).
Therefore, these cells show delayed chromosome decondensation
post-mitosis equal to cultured human fibroblasts with MCPH1
mutations [7]. In summary, these results confirm a defective
chromosome condensation in the Mcph1
gt/gt cells similar to
MCPH1-deficiency in human.
Meiosis and Fertility
We were interested whether the gene trap mutation may also
perturb meiosis and in particular meiotic chromosome condensa-
tion. Therefore, male meiosis was investigated by the analyses of
testes sections and conventional chromosome preparations. Testes
sections show perfectly normal morphology with numerous mature
sperm in the lumen. More than 20 metaphase I cells were
investigated all of which showed perfectly normal pairing of the
homologues. Thus, the analyses of male meiosis revealed normal
progression through both meiotic divisions and the production of
mature gametes (Figure 5).
In addition, pairing homozygous Mcph1
gt/gt mice inter se
revealed no reduction in fertility. Average litter size of gt/gt
animals was 6.362.8 which is not significantly different from that
of wild type animals 6.962.9 (two-tailed P-value, P=0.441)
(Figure 2C). Likewise, we could not identify any sex specific
differences in the breeding success.
DNA Damage
Several reports attribute a crucial function in DNA damage
response to microcephalin/BRIT1. Xu et al. (2004) and Lin et al.
(2005) observed that downregulation of MCPH1 by RNAi
Figure 4. Analyses of chromosome condensation behavior in Mcph1
gt/gt cells. (A) Determination of the fraction of prophase-like cells
(PLCs) and metaphase indices in Mcph1
gt/gt and WT cell cultures. Mcph1
gt/gt show significantly increased proportions of PLCs: 7.7% vs. 1.0% in WT cell
cultures (x
2=1306.49, p,0.001). In contrast, metaphase indices (MI) are within the range of wild type cell cultures, indicating comparable
proliferative activity. (B) Cell cycle analysis after 3H-thymidine-pulse-labeling of logarithmically growing fibroblast cell lines from Mcph1
gt/gt (grey
diamonds) and WT animals (white squares). The first labeled cells with prophase-like appearance in the Mcph1
gt/gt cells occur within the first hour
after the pulse. (C) Proportion of cells with condensed chromosomes postmitosis in Mcph1
gt/gt and control cells. Many Cytochalasin-treated
binucleated G1-cells of Mcph1
gt/gt cells show condensed chromatin (19.8%) compared with control cells (2.8%). (D) To the left one exemplary cell
displaying premature chromosome condensation in the G2 phase of the cell cycle defined by focal (centromeric) staining of phosphorylated histone
H3(-Ser10), note that the phosphorylation has not spread into the chromosome arms. To the right two cells showing delayed decondensation in G1
post-mitosis defined by the formation of a midbody.
doi:10.1371/journal.pone.0009242.g004
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response in U2OS osteosarcoma cells. In contrast, accurate G2/
M checkpoint function had previously been reported in MCPH1-
mutated patient-derived lymphoblastoid cell lines [4]. In order to
examine the DNA-damage induced G2/M checkpoint response in
Mcph1
gt/gt mouse fibroblasts, phospho-histone H3 (Ser
10) (p-H3)
expression was studied as a mitotic marker. Using G2 phase
irradiation under exactly identical conditions as described by Xu
et al. (2004), flow cytometric analysis revealed a decrease of p-H3-
positive Mcph1
gt/gt fibroblasts by 87.2% 2 h after provision of 4
Gy. For comparison, wildtype mouse fibroblasts treated in the
same way showed a reduction of p-H3-positive cells by 81.2%. In
triplicate experiments, these figures were not statistically signifi-
cantly different (single-tailed t-test, p=0.189). The corresponding
figures 4 h after exposure towards 4 Gy were 86.8% p-H3
reduction in Mcph1
gt/gt fibroblasts and 79.6% reduction in
wildtype fibroblasts (single-tailed t-test, p=0.200). Therefore,
decreased Mcph1 expression in Mcph1
gt/gt mouse fibroblasts is
not associated with defective G2/M checkpoint functions. These
data show that Mcph1
gt/gt mouse fibroblasts can efficiently
prevent mitotic entry despite the gene trap mutation.
Moreover, it was reported that microcephalin function is
essential for targeting DNA damage response proteins such as
53BP1 to DNA repair foci at the sites of DNA double strand
breaks (Rai et al. 2006). The targeting of microcephalin/BRIT1
itself to the repair foci was assigned to the C-terminal BRCT-
domains (Wood et al. 2007; Jeffers et al. 2008). Therefore, we
explored whether the gene trap deleting the last C-terminal BRCT
domain interfered with foci formation following DNA double
strand break induction. In contrast to the reported results, the
formation of 53BP1 foci that co-localized to cH2AX-foci seemed
not disturbed in diploid fibroblast cell cultures of Mcph1
gt/gt mice
following 2 hours treatment with 0.5 mg/ml of the radiomimetic
agent adriamycin (Figure 6A). We did not observe any obvious
difference in the formation of repair foci compared to wild type
cell cultures. Possibly, this may be explained by residual wild type
Mcph1 protein. Also the truncated protein produced by the gene
trap allele may be sufficient to enable 53BP1 foci formation.
Therefore, we repeated the experiment with cultures of trans-
formed fibroblasts of wild type and Mcph1
gt/gt mice and depleted
the cells of both Mcph1 wild type and Mcph1
gt alleles by RNAi.
Quantitative real time PCR showed that Mcph1 and Mcph1
gt
were efficiently depleted by .70% (Figure S3). Determination of
the number of prophase-like cells confirmed that the depletion was
efficient enough to induce the cellular phenotype of misregulated
chromosome condensation (Figure S3). In wild type cells the
number of prophase-like cells increased from 2.0%60.3 to
11.8%61.6 after siRNA treatment while the percentage of PLCs
was not increased in Mcph1
gt/gt cells (11.1%62.6 in the mock
treated cells, 12,1%62,2 in the siRNA treated cells). Again, there
was no obvious difference in the formation of 53BP1-foci between
wild type and Mcph1
gt/gt cells following the induction of DNA
double strand breaks for 2 hs with 10 mg/ml bleomycin.
Surprisingly, there was also no obvious difference between RNAi
treated and mock treated cells neither in wt nor in Mcph1
gt/gt cells
(see Figure 6B for overview pictures of the different preparations).
To exclude a more subtle effect the different preparations were
analyzed quantitatively. Several overview pictures were taken
randomly from different areas of each preparation. The pictures
were coded and foci numbers in .100 cells were scored for each
sample from these coded pictures of single focal planes by four
different evaluators in two experiments. Also the quantitative
analysis revealed no difference between Mcph1
gt/gt and wild type
cells. As well, there was no difference in foci numbers between
RNAi treated and mock treated cells (Figure 6C).
It was also reported that RNAi against MCPH1 results in
chromosomal aberrations [14]. However, we do not observe an
increase in chromosomal breakage rates in cells of Mcph1
gt/gt
mice. Induced chromosomal breakage rates of Mcph1
gt/gt-cells
following ionizing irradiation (2 Gy) were not different from those
of wild type cells treated with the same dose (Figure 6D). Three gt/
gt cell lines were compared to three wt cell lines. Chromosomes
were prepared 3 h and 6 h after irradiation. The number of breaks
was scored for 25 metaphases of each cell line at each data point.
Unirradiated cell cultures were treated in exactly the same way as
their irradiated counterparts. Combined breakage rates for all gt/
gt-cultures were 3.36 breaks/cell 60.66 (3 h after irradiation with
2 Gy) and 1.45 breaks/cell 60.16 (6 h after irradiation with 2 Gy).
The corresponding breakage rates for the wt-cultures were
3.03 breaks/cell 60.76 and 1.40 breaks/cell 60.53, respectively.
Effects on Gene Expression
It was repeatedly reported that MCPH1 would regulate protein
and transcript levels of other genes such as hTERT, BRCA1 and
Figure 5. Meiosis in male Mcph1
gt/gt germ cells. (A) Section of a testes biopsy from a male Mcph1
gt/gt showing normal morphology, (B)
diakinesis/metaphase I from a male Mcph1
gt/gt reveals normal pairing of the autosomal bivalents and the sex chromosomes (XY), (C) normal
metaphase II cell from a male Mcph1
gt/gt. For comparison a diakinesis/metaphase I (D) and a metaphase II cell (E) from a male wt/wt mouse are
presented.
doi:10.1371/journal.pone.0009242.g005
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gt/gt cell culture. (A) 53BP1 (green) localizes to repair foci in Mcph1
gt/gt cells induced by treatment
with the radiomimetic drug adriamycin. The foci co-localize with c-H2AX foci (red) confirming that the focal staining represents indeed repair foci at
the sites of DNA double strand breaks. (B) Overview pictures of 53BP1 foci formation (red) in wild type and Mcph1
gt/gt cells following the induction of
DNA double strand breaks by the radiomimetic drug bleomycin and treatment with Mcph1-siRNAs (bottom) and mock treatment (top). No obvious
difference is detectable in the Mcph1
gt/gt cells or siRNA treated cells compared to the controls. (C) Quantitative analyses of the same experiments. No
significant difference in the formation of 53BP1 foci in the Mcph1
gt/gt cells or siRNA treated cells compared to the controls could be detected. (D)
Chromosomal breakage rates in Mcph1
gt/gt and wt cells following ionizing irradiation with 2 Gy. There is no significant difference between wild type
and Mcph1
gt/gt cells.
doi:10.1371/journal.pone.0009242.g006
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cephalin/BRIT1 may function in transcriptional regulation [33].
Very recently an interaction of microcephalin/BRIT1 with the
transcription factor E2F1 was described [34]. In this study, the C-
terminal BRCT-domains were identified to be crucial for E2F1
binding and activation. Therefore, we investigated the effects of
the gene trap mutation on gene expression in different tissues on
RNA and protein level. We performed expression analyses using
Sentrix
H Mouse-6 Expression BeadChip (Illumina, San Diego, CA,
USA) comparing gene expression in brain, liver, and spleen of 3
Mcph1
gt/gt and 3 wildtype animals. (All information including the
raw data can be downloaded from http://ws.molgen.mpg.de/ws/
311013/MIAME.rar.) These analyses revealed no specific patterns
of differentially regulated genes in the animal bearing the gene
trap. In particular, in none of the three analyzed tissues did we find
an enrichment of regulated genes in any of the pathways
microcephalin/BRIT1 is known to be involved. (See Tables S1
and S2 (A-C) for the whole lists of genes differentially expressed at
a significance level of P#0.05, comparing tissues from Mcph1
gt/gt
and wild type animals). Combining the data of all three tissues
resulted in 39 genes commonly upregulated and 23 genes
commonly downregulated with a P-value #0.05 in all three
tissues of the Mcph1
gt/gt animals investigated (Figure S4 and
Tables S1 and S2 (D-G)). We were unable to assign a specific
function to these groups of genes. Interestingly, in all tissues we
found more genes up- than downregulated. This was somewhat
surprising given the reported role of microcephalin/BRIT1 in
transcriptional activation [34]. More specifically, there was no
significant reduction in the expression levels of Chk1, Brca1,
Topbp1, Rad51, Ddb2, p73, Apaf1, or caspases which were all
described to show reduced expression following MCPH1 knock-
downs [34] (Tables S3, S4, S5).
In our proteomic investigation of Mcph1
gt/gt-brains we detected
4,006 protein isoforms. A total of 63 protein isoform alterations
were found when comparing Mcph1
gt/gt to control brains. In
contrast to the expression profiling, in this assay more protein
isoforms (52) appeared to be downregulated than upregulated (11)
(Table S6). Comparing the Mcph1
gt/gt data to proteomics studies
of three neurodegenerative disorders (ND) it became obvious that
the number of changes occurring in the brain of gt/gt mice,
however, are a lot less numerous than in ND. We investigated
mouse models of Huntington’s- (HD) [28], Alzheimer’s- (AD) [24]
and Parkinson’s disease (PD) [27]. In the brains of these model
organisms a maximum of 240, 82 and 153 protein isoforms were
altered compared to wild type animals, respectively. 4,283, 1,769
and 3,293 protein isoforms were studied for each ND, respectively.
Correcting for the difference we obtained 5.6%, 4.6% and 4.6% of
isoforms altered for HD, AD and PD. In Mcph1
gt/gt-brains,
however, only 1.6% of all protein isoforms were altered. This is
about 2.5 fold lower when compared to the neurodegenerative
diseases described above. The lower number of changes correlates
with a very mild phenotype found in MCPH1
gt/gt mice.
Discussion
We describe here the first mammalian model with misregulated
mitotic chromosome condensation due to defective Mcph1
function. The gene product of the mouse Mcph1 gene is truncated
by a gene trap within intron 12 of the gene which results in the
deletion of the last BRCT-domain of the protein. The observed
defect in the regulation of chromosome compaction resembles that
observed in human PCC syndrome. The chromatin condenses
prematurely in the G2 phase of the cell cycle, shortly after
completing replication. Post-mitosis the decondensation of the
chromatin is delayed. This results in an elevated fraction of cells
with condensed chromatin displaying a prophase-like appearance.
This unique cellular phenotype proves that the protein function is
impaired although the gene trap results in a deletion of only 97 C-
terminal amino acids. In addition, our data suggest that the
addition of the b-geo reporter interferes with normal function
and/or folding of the protein. In this context it seems noteworthy
that in contrast all germ line mutations in human MCPH1
reported so far affect the N-terminal part of the protein. Also, it
was recently reported that it is indeed the N-terminal BRCT-
domain that is required for the regulation of chromosome
condensation in mouse embryonic fibroblasts [17]. Our results,
however, suggest that the whole Mcph1 protein may be necessary
for an unperturbed function in the regulation of chromosome
condensation. The observation that the defective chromosome
condensation occurs only in the homozygous but not the
heterozygous cell lines makes a dominant-negative effect exerted
by the b-geo-reporter unlikely.
Despite the defect in chromosome condensation due to the
obviously impaired function of the protein, the Mcph1
gt/gt-mice
do not show any striking physical phenotype. This may not be
really surprising, as the major clinical symptom of the human
disorder is the severe microcephaly due to a marked reduction in
the size of the cerebral cortex [5,6]. The reduction of the cerebral
cortex, however, does not result in significant neurological
dysfunction apart from a moderate reduction in cognitive ability
[8]. Evolutionary, the enormous encephalization that has occurred
in the lineage leading to modern humans is mainly reflected in an
increase of the cortical size of the human brain. Therefore, a
defect in neurogenic mitosis, which is probably the reason for the
microcephaly in humans bearing MCPH1 mutations, may have
only a marginal impact on the formation of mouse brain, that
could remain undetected by the methods applied. In this context it
should also be noted that the residual expression of the wild type
allele was highest in brain (approximately 28%) and it is entirely
conceivable that the residual protein allows a normal brain
development. Also Mcph1 isoforms that may be unperturbed by
the gene trap mutation could substitute for the function of the
truncated protein.
What seems to be more surprising is that meiosis appears to be
undisturbed by the defect. At least, we did not observe any
limitation in the reproductive capacity of gt/gt mice of both sexes
and the morphology of meiosis I spreads of male Mcph1
gt/gt mice
was normal. Therefore, microcephalin/BRIT1 may either not
function in meiotic chromosome condensation or proper meiotic
function may not be harmed by an abnormal condensation
behavior (undetectable in our preparations). Previously, we have
shown that the condensation defect in human cells has no impact
on the proper execution of the main mitotic function, that is the
segregation of sister chromatids to the daughter cells [4]. However,
meiotic division may be more susceptible. Therefore, it will be
interesting to analyze the meiotic behavior of chromosomes in
Mcph1
gt/gt mice in more detail.
While, to the best of our knowledge, there are no reports of
associated diseases in MCPH1 patients, we observed a significantly
shortened overall lifespan of Mcph1
gt/gt animals (Figure 2D). It
will be very important to further investigate the effects of the
mutation on the health of the animals and its potential relevance
for the clinical prognosis of human MCPH1 patients. Unfortu-
nately, we were so far unable to delineate the reasons for the
premature deaths in the Mcph1
gt/gt animals. But it is tempting to
speculate that the shortening of the lifespan is linked to the
reported crucial role of microcephalin/BRIT1 in DNA damage
response [33,35].
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BRIT1 in the human U2OS cell line results in increased
chromosomal aberration rates and prevents foci formation of
important regulators of the DNA damage response, such as
53BP1. Importantly, several studies assign the decisive role in
the execution of the DNA damage response functions of the
protein to the C-terminal BRCT-domains [14,15,16]. Deletion
of the C-terminal BRCT-domain alone is sufficient to abolish
the ability of microcephalin/BRIT1 to form radiation induced
foci itself. Moreover, while the exogenous expression of an
RNAi-resistant full length MCPH1-transcript was sufficient to
rescue this effect of the MCPH1 knockdown, a transcript that
w a si s o l a t e di nah u m a nb r e a s tc ancer specimen lacking the C-
terminal BRCT-domains was not able to complement the
defect. It was also reported that microcephalin/BRIT1 is
involved in transcriptional activation of many important genes
of the DNA damage response. Interestingly, it was shown that
the C-terminal BRCT domains are also essential in exerting this
function.
Hence, it remains to be explained why our investigations show
that repair foci formation, G2/M checkpoint control, and
chromosomal breakage rates in the Mcph1
gt/gt cell cultures are
not affected by the genetrap mutation deleting the C-terminal
BRCT-domain. Also the expression profiling of the Mcph1
gt/gt
mice did not show a shifted expression of key components of the
DNA damage response network, such as BRCA1 and CHK1 that
were published to be affected by MCPH1 knockdowns.
Certainly, again, it may be possible that residual wild type
protein or even the truncated protein encoded by the gene trap
allele exert these functions. However, also the depletion of wild
type Mcph1 and Mcph1
gt by RNAi did not impair the formation
of 53BP1 foci neither in wt nor in Mcph1
gt/gt cells. Although it
may be possible that the knockdown in our experiments was not
efficient enough to induce the damage response phenotype, this
seems unlikely as it was efficient enough to induce defective
chromosome condensation in wt cells.
Therefore, although it was shown that Mcph1 co-localizes with
c-H2AX in repair foci also in mice cells [17], we can not
ultimately rule out that in some aspects the role of Mcph1 in DNA
damage response may differ between mice and human. However,
also the function of Mcph1 in the regulation of chromosome
condensation may be more dosage sensitive than some of its other
functions. We can also not exclude that the use of radiomimetics
may result in different results compared to double strand break
induction by ionizing irradiation.
In this context it seems noteworthy, that we did not observe
radiosensitivity in human MCPH1 patient cell lines bearing
homozygous truncating mutations (T143NfsX5) [4] and that
53BP1 also forms regular DNA repair foci that co-localize with c-
H2AX in MCPH1 patient fibroblasts (our own unpublished
observations).
Further experiments will be necessary to explain these
conflicting results. The more so as, while our manuscript was in
revision, another report on the functions of MCPH1 in DNA
damage response was published and the authors of this study
equally did not observe an effect of the depletion of hMCPH1 on
53BP1 foci formation [36].
In conclusion, we describe here the first Mcph1 mouse model.
We could show that a mutation caused by a gene trap vector
results in impaired Mcph1 function. Evidence comes from the
confirmation of the defect in the regulation of chromosome
condensation in proliferating cells of the Mcph1
gt/gt-mice. This
defect resembles that described for PCC syndrome a human
genetic disorder caused by MCPH1 mutations. Most importantly,
the overall life span of the Mcph1
gt/gt is significantly shortened.
Thus, the mouse model should prove useful for the further
delineating of the consequences of MCPH1 mutations on patient’s
health and to unravel the molecular mechanisms which determine
microcephalin/BRIT functions.
Supporting Information
Figure S1 Thymidine pulse labeling. Cell cycle analysis after
3H-thymidine-pulse-labeling of logarithmically growing trans-
formed fibroblast cell lines from Mcph1
gt/gt (grey diamonds) and
WT animals (white squares). One hour after the pulse the
percentage of labeled prophases and/or prophase-like cells is
significantly higher in the Mcph1
gt/gt cells compared to control
cells.
Found at: doi:10.1371/journal.pone.0009242.s001 (0.17 MB TIF)
Figure S2 p-H3-labeling. An exemplary normal prophase cell
displaying full histone H3-(Ser10) phosphorylation.
Found at: doi:10.1371/journal.pone.0009242.s002 (0.94 MB TIF)
Figure S3 Determination of the depletion success. Mcph1 and
Mcph1
gt were depleted by RNAi. (A) The depletion induced the
cellular phenotype of defective chromosome condensation in the
wt cells. Quantitative analysis of the proportion of prophase-like
cells to the left and exemplary prophase-like cells from the RNAi
treated wt cell cultures to the right. (B) Relative quantification of
the wild type Mcph1 allele following RNAi in wild type and
Mcph1
gt/gt cells by quantitative real time PCR. (C) Relative
quantification of the genetrap allele following RNAi in Mcph1
gt/gt
cells by quantitative real time PCR.
Found at: doi:10.1371/journal.pone.0009242.s003 (0.35 MB TIF)
Figure S4 Expression profiling of Mcph1
gt/gt tissues. (A) Venn-
diagram of genes upregulated (P-value #0.05) in different tissues
of Mcph1
gt/gt mice and (B) Venn-diagram of genes downregulated
(P-value #0.05) in different tissues of Mcph1
gt/gt mice.
Found at: doi:10.1371/journal.pone.0009242.s004 (0.18 MB TIF)
Table S1 Downregulated genes (Diff_Score #213/P#0.05) in
different Mcph1
gt/gt tissues.
Found at: doi:10.1371/journal.pone.0009242.s005 (0.33 MB
XLS)
Table S2 Upregulated genes (Diff_Score $13/P#0.05) in
different Mcph1
gt/gt tissues.
Found at: doi:10.1371/journal.pone.0009242.s006 (0.57 MB
XLS)
Table S3 Expression of potential Mcph1-targets in brain of
Mcph1
gt/gt mice.
Found at: doi:10.1371/journal.pone.0009242.s007 (0.02 MB
XLS)
Table S4 Expression of potential Mcph1-targets in liver of
Mcph1
gt/gt mice.
Found at: doi:10.1371/journal.pone.0009242.s008 (0.02 MB
XLS)
Table S5 Expression of potential Mcph1-targets in spleen of
Mcph1
gt/gt mice.
Found at: doi:10.1371/journal.pone.0009242.s009 (0.02 MB
XLS)
Table S6 Comparing protein expression changes between
Mcph1
gt/gt and mouse models of three common neurodegener-
ative diseases.
Found at: doi:10.1371/journal.pone.0009242.s010 (0.02 MB
DOC)
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